The average American should start regular colorectal cancer screenings at the age of 45, according to new guidelines issued by the American Cancer Society (ACS). Previous recommendations from the organization suggested people at average risk of the condition should begin a screening schedule at the...

Concern over the cost of cost of health care resulted in more than one-quarter (27 percent) of American adults forgoing medical treatment over concerns about their ability to pay, according to a recent report. The Federal Reserve’s Report on the Economic Well-Being of US Households in 2017...

A new treatment option will soon be available for children aged five and over with asthma following the US Food and Drug Administration’s (FDA) decision to expand its approval of the GlaxoSmithKline (GSK) Arnuity Ellipta (fluticasone furoate) inhaler.  The medication was first approved...

One in three waterborne disease outbreaks in the United States between 2000 and 2014 occurred in hotel pools and hot tubs, according to recent findings published by the Centers for Disease Control and Prevention (CDC). The  Morbidity and Mortality Weekly Report found more than half the...

Senior patients with diabetes could be more than $350 better off each year if a share of negotiated manufacturer rebates is passed on the patients at the point of sale, according to recent IHS Markit analysis commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA). Passing...

A “novel” new preventative treatment for migraines in adults, which works by blocking the activity of a molecule involved in migraine attacks, has been approved by the US Food and Drug Administration (FDA). Approval for Aimovig (erenumab-aooe) was granted to Amgen Inc following three...

Patients with anemia caused by chronic kidney disease, chemotherapy, or those with HIV who take Retrovir (zidovudine) will soon have a new medication option in the form of Retacrit (epoetin alfa-epbx). The drug is the first biosimilar for epoetin-alfa to gain US Food and Drug Administration (FDA)...

The US Food and Drug Administration (FDA) has granted approval to Gilenya (fingolimod) as a treatment for children and adolescents with multiple sclerosis (MS). The Novartis medication is the first drug approved by the FDA for treatment of pediatric patients with MS.  Gilenya first gained FDA...

President Donald Trump has unveiled a “blueprint” to lower the price of prescription drugs in the United States. The plans include building on the existing administrative efforts of the US Food and Drug Administration (FDA) to increase generic drug approvals, reforms to the Medicare...

The US Food and Drug Administration (FDA) has approved the protein kinase inhibitor Tagrisso (osimertinib) as a first-line treatment option for certain patients with metastatic non-small cell lung carcinoma (NSCLC). Earlier this month, AstraZeneca presented new data from a Phase III FLAURA trial...

GlaxoSmithKline’s once-daily triple therapy, the Trelegy Ellipta (fluticasone furoate, umeclidinium, vilanterol), is superior to dual combination therapies in reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD) with a history of exacerbations, new research...

All lots of the Euphoric male enhancement supplement have been voluntarily recalled by Epic Products, LLC after the US Food and Drug Administration (FDA) discovered the presence of undeclared prescription erectile dysfunction products. The product, packaged in one count blister cards, three count...

The US Food and Drug Administration (FDA) has taken steps to restrict the sale and distribution of the Essure device, citing the lack of awareness of the risks and benefits among many women opting for this form of contraception as one of its main concerns. “Based on our review of a growing...

The US Food and Drug Administration (FDA) has approved Crysvita (burosumab) as a treatment for a rare form of inherited rickets. It is the first drug therapy approved as a treatment for x-linked hypophosphatemia (XLH) with evidence of bone disease in children over one year of age and adolescents...

The US Food and Drug Administration (FDA) has permitted marketing of a medical device that utilizes artificial intelligence (AI) to detect certain eye problems related to diabetes. It is the first device of its kind to harness AI to detect diabetic retinopathy considered greater than a mild level...

Adult diabetes may fall into five different categories rather than type 1 and type 2 diabetes, according to new research. A study conducted by researchers at Lund University in Sweden found new classifications for diabetes, each with their own distinct genetics and characteristics. It is hoped the...

The US Food and Drug Administration (FDA) has issued a warning to consumers about unapproved erectile dysfunction drugs advertised nationwide on broadcast and internet radio platforms. The products, advertised on iHeartRadio and other stations, have been advertised as a “healthy man...

Cancer medication Blincyto (blinatumomab) has received accelerated approval as a treatment to reduce the risk of relapse in certain patients with B-cell precursor acute lymphoblastic leukemia (ALL). Under the latest US Food and Drug Administration (FDA) approval, Blincyto is indicated for adults...

The US Food and Drug Administration (FDA) has approved Ilumya (tildrakizumab-asmn) for treating adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. The Sun Pharma drug was granted approval following two Phase 3 clinical trials featuring 926...

In an exciting breakthrough for patients with diabetes, the US Food and Drug Administration (FDA) has authorized the marketing of the Dexcom G6 integrated continuous glucose monitoring system (iCGM). The latest version of the continuous glucose monitoring system is indicated for use by patients...